PIEZO1 and neoplasm: These findings highlight the need to precisely tune Piezo1 activity—leveraging its benefits in acute mechanotransduction while avoiding the detrimental effects of chronic overactivation, especially in the design of CAR T cells intended for long-term persistence and activity within mechanically stressful tumor environments.